Experimental Drug Provides Lasting Relief For Bleeding Condition

• Dennis Thompson HealthDay Reporter
• December 12, 2025
• Full Page

More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.

Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe plate...